An interventional study of single burr hole in Chronic Subdural Hematoma, sponsored by Zagazig University. Completed. Open to participants aged 19 Years to 90 Years. Per ClinicalTrials.gov, last updated 2018-02-27.
Sponsored by Zagazig University · Not applicable, Interventional, and Treatment
Aim of the work: Is to evaluate the prognosis of single burr hole under local anesthesia in management of CSDH according to clinical picture, risk factors, and age.
Patients and methods: We studied 67 consecutive patients with CSDH operated by single burr hole craniostomy under local anaesthesia from Mars, 2014 to February, 2015 in Zagazig University Hospitals according to the aetiology, clinical picture, risk factors, and complications.
112 studies on the registry are indexed under Hematoma, Subdural, Chronic; 49 are open to participants now.
This study's enrollment of 67 is below the median of 185 across 86 interventional studies indexed under Hematoma, Subdural, Chronic.
Browse Hematoma, Subdural, Chronic studies →Zagazig University is the lead sponsor of 459 studies on the registry; 77 are open to participants now.
Of its 5 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Counted across the registry records on this site, refreshed daily.
Inclusion Criteria:chronic subdural hematoma above 19 years old -
Exclusion Criteria:age below 19 years acute subduralhematoma uncoperative patients
-
patients undergoing surgery for chronic subdural hematoma by single burr hole under local anaesthesia
Procedure: single burr hole
patients with CSDH operated by single burr hole craniostomy under local anaesthesia
Glasgow Outcome Scale
The Glasgow Outcome Scale was used as measuremabilityent for neurological oucome after surgery.The patients were classified as as dead, persistant vegetative state, severe disability, moderate disability, and mild dis
Time frame: 6 months postoperative
No study locations are listed for this record.
Plan to share: Undecided
No publications or documents are linked to this record.
Ran from Mar 2014 to primary completion in Feb 2015, 11 months.
Of 44 interventional studies with no phase under Hematoma, Subdural, Chronic, half reached primary completion within 45 months of starting (the median), counting those still running; a quarter within 37 and three quarters within 70. This study's 11 months is below that.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Feb 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.